Close

Rating History for Prelude Therapeutics (PRLD) by Morgan Stanley

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/19/2023 Jeffrey Hung Downgrade Underweight
(Equalweight)
4.00
(10.00)
4.35
(5.69)
30.8% Details